clpmag

Roche Adds Molecular Testing Capacity in Democratic Republic of Congo Amid Ebola Outbreak

Roche supplied two molecular testing systems and in the DRC to support PCR test validation for Bundibugyo virus amid Ebola outbreak.
MarketScreener

Roche Diagnostics Provides Molecular Testing Instruments To Institut National De Santé Publique To Support Ebola Testing Capacity In The Democratic Republic Of Congo

Roche Diagnostics has provided two molecular testing instruments to the Institut National de Santé Publique (INSP), which is supporting the DRC's Ministry of Health-led Ebola response. Roche will ...

Countable Labs Sets a New Standard in Molecular Testing for Hematologic Malignancy Clinical Applications

Countable Labs announces Ancora assays for molecular testing of hematologic malignancy, marking the company's entry into clinical markets.
Medical Product Outsourcing

FDA Grants Emergency Use Authorization to Seegene for its Multiplex PCR Assay

Seegene USA Inc. has received FDA Emergency Use Authorization for the Allplex HSV1-1&2/VZV2/MPXV3 Assay, a multiplex ...
BIOENGINEER

Glioma Diagnosis Goes Molecular, But Most of the World Cannot Afford It

A new review warns that the molecular tests defining modern glioma diagnosis remain out of reach for most of the world, and ...
RTTNews

Roche Boosts Ebola Testing In Congo Region With Molecular Equipment As Outbreak Spreads

On Wednesday, Roche's ( RHHBY) diagnostic division, Roche Diagnostics has provided two molecular testing instruments to the Institut National de Sante Publique (INSP) to strengthen laboratory capacity ...
BIOENGINEER

Molecular Tests Reshape Diagnosis of Leishmaniasis, Review Finds

Leishmaniasis, a parasitic disease transmitted by sandflies, remains one of the most under-recognized threats to global ...
Nasdaq

Roche introduces the cobas 5800, a new molecular diagnostic system to expand access to PCR testing in the U.S.

cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...
Business Wire

Minute Molecular’s DASH Point-of-Care COVID-19 Rapid PCR Test Gains FDA Emergency Use Authorization

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
BioSpace

Co-Diagnostics to Showcase Co-Dx PCR Platform* and MTB Test at WHX Labs Johannesburg, Highlight Ebola Assay Development

Attendees are invited to join Co-Dx at Booth # H3.L38, where the Company will showcase the Co-Dx PCR platform and the Co-Dx™ ...

Point-of-Care Molecular Diagnostics Market Poised for Growth Through 2034, Driven by Rapid Testing Demand, Decentralized Care and Diagnostic Innovation

Demand is shifting to rapid, decentralized and at-home molecular testing, creating opportunities in consumables, multiplex panels, portable PCR, CRISPR diagnostics and Asia-Pacific expansion.Dublin, ...

Co-Diagnostics Tests ReadyGo Tech for PCR Platform

Detailed price information for Co-Diagnostics Inc (CODX-Q) from The Globe and Mail including charting and trades.